 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

Current Price	$3.29
Prev Close	$2.79
Open	$2.99
Dividend Yield	0.00%
50-Day Moving Average	$2.73
Beta	2.01
Avg. Volume	7.75M
PE Ratio	-3.12

52-Week High	$7.80
52-Week Low	$1.21
Market Capitalization	$1.43B
EPS	-$1.05
Price to Book	-2.62
Revenue Per Employee	$808.28
Enterprise Value/EBITDA	-4.26

IBRX ImmunityBio Inc

About

Feed

Fundamentals

News